June 2026 by the Numbers: Record Highs, Weak Breadth and a Stronger Dollar
Financial market statistics and the June 2026 Health Scores point to a more uncertain environment than surface-level indicators might suggest. Only one third of the instruments under review exhibit a sufficiently strong directional trend to be classified as trending.
The first days of June 2026 brought a wave of record highs. On June 1 and 2, the S&P 500 (SPY) closed above the 7,600 mark for the first time ever, the Nasdaq Composite broke through 27,000, and the Nasdaq-100 surpassed 30,000 points. On June 17, Europe joined the rally: both Milan (FTSE MIB) and Madrid (IBEX 35) reached new all-time highs during the same trading session.
That synchronization did not last through the end of the month. By June 30, only the Dow Jones Industrial Average and the Russell 2000 (IWM) closed at new record highs, with the Dow posting its second consecutive record close. The S&P 500 and the Nasdaq finished approximately 2% and more than 3%, respectively, below their early-June peaks, while the largest technology stocks remained even further below their 52-week highs. Milan ended the month roughly 2% below its June 17 record, whereas Madrid remained within striking distance of its monthly high.
Another indicator reinforces this breakdown in market synchronization—this time from our proprietary scoring system. By June 11, the momentum reading for U.S. equities, measured through the S&P 500, had already fallen from +5.55% at the beginning of the month to -0.21%, where it remained essentially unchanged through month-end. The market regime shifted from expansion to slowdown during the first half of June. The S&P 500 and the Nasdaq ultimately confirmed that signal by finishing the month below their highs. The Dow Jones and the Russell 2000, whose performance is less dependent on mega-cap technology stocks, did not follow the same pattern. This is the first key takeaway from the report: June was not a month in which the entire U.S. market advanced together—it was the month in which the market split into two distinct camps.
The second major development of the month concerns the U.S. dollar. The U.S. Dollar Index ended June with the highest health score among all 130 instruments tracked by our system—not just among currencies, but across the entire universe. At the opposite end, the EUR/USD exchange rate ranked among the weakest readings overall. The Japanese yen weakened along the same lines, with USD/JPY reaching a five-year high at month-end. Three different indicators, all pointing to the same underlying trend.
Beneath the Surface
Looking across the system as a whole, the data tell a similar story. The average health score of all tracked instruments rose to 51.6, up 5.3 points from the previous month. Average momentum also improved, climbing from 39.3 to 50.7—a proportionally even larger increase than health. However, the share of instruments in clearly positive territory increased from just 13.8% to 34.6%: a meaningful improvement, yet still a minority of the total universe. Meanwhile, the percentage of instruments trading above their 200-day moving average—a more structural, long-term measure—rose by only 4.6 percentage points, reaching 60.8%.
The gap between these two figures captures the central message of the month.
🔒 Subscriber-only content. Activate 14-day free trial or Login here
